NSE is an isoenzyme released by neurons and neuroendocrine cells, routinely employed as a biomarker in the diagnosis, staging, and monitoring of SCLC, particularly when levels exceed 25 ng/mL [7]. Here, ENO2 is linked to small cell lung carcinoma.